Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

Details for Australian Patent Application No. 2012202570 (hide)

Owner Albany Molecular Research, Inc. Bristol-Myers Squibb Company

Inventors Molino, Bruce F.; Liu, Shuang; Sambandam, Aruna; Guzzo, Peter R.; Hu, Min; Zha, Congxiang; Nacro, Kassoum; Manning, David D.; Isherwood, Matthew L.; Fleming, Kristen N.; Cui, Wenge; Olson, Richard E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012202570

Parent 2006270071

Filing date 2 May 2012

Wipo publication date 24 May 2012

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

17 May 2012 Complete Application Filed

24 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202570

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202571-Delaying or Preventing Onset of Multiple Sclerosis

2012202569-EPHA2 agonistic monoclonal antibodies and methods of use thereof